












151Cerebral hemodynamic beneﬁts after carotid artery
stenting in patients with near occlusion
Fumiaki Oka, MD, PhD,a Hideyuki Ishihara, MD, PhD,a Shoichi Kato, MD, PhD,a
Takayuki Oku, MD, PhD,a Akiko Yamane, MD,a Ichiro Kunitugu, MD, PhD,b and
Michiyasu Suzuki, MD, PhD,a Yamaguchi, Japan
Objective: The natural history and management of patients with near occlusion (NO) of the internal carotid artery are
controversial. In particular, it is unclear whether cerebral hemodynamics are compromised in these patients and whether
improvement by carotid revascularization leads to the prevention of ischemic stroke. In this study, we measured cerebral
blood ﬂow (CBF) and cerebrovascular reactivity (CVR) using single-photon emission computed tomography before and
after carotid artery stenting (CAS) for NO to examine the effectiveness of CAS from the perspective of cerebral
hemodynamics.
Methods: CAS was performed in 15 patients with NO and in 78 with severe stenosis ($70%) but without NO at our
institution. Resting CBF and CVR to acetazolamide were measured using N-isopropyl-p-[I-123] iodoamphetamine
single-photon emission computed tomography before and at 3 to 6 months after CAS. We also measured CBF using the
same method for healthy individuals and compared the results among the three groups.
Results: CAS was successfully performed in all patients. Before CAS, the mean resting CBF was 26.686 4.23 mL/100 g/min,
and the mean CVR wasL0.8% 6 15.1% in the patients with NO, both of which were signiﬁcantly lower than in patients
with severe stenosis without NO and in healthy individuals. After CAS, the mean resting CBF and mean CVR in patients
with NO increased signiﬁcantly to 30.07 6 5.67 mL/100 g/min and 37.0% 6 21.4%, respectively, and there were no
signiﬁcant differences among the three groups.
Conclusions: Before CAS, patients with NO were more hemodynamically compromised than those with severe stenosis
without NO. After CAS, signiﬁcant cerebral hemodynamic improvement and normalization occurred long-term. Thus,
from a hemodynamic perspective, CAS was effective in patients with NO. (J Vasc Surg 2013;58:1512-7.)Near occlusion (NO) of the cervical internal carotid
artery (ICA) was ﬁrst described as a poststenotic carotid
slim sign by Lippman et al.1 NO of the ICA is now deﬁned
as the presence in the ICA of an atheromatous plaque
causing severe stenosis, a drop in perfusion pressure distal
to the stenosis, and diminished or absent perfusion of the
ipsilateral intracranial carotid ﬂow.2 The natural history
and management of patients with NO are controversial.
The North American Symptomatic Carotid Endarterec-
tomy Trial (NASCET) and European Carotid Surgery Trial
(ECST) found that NO or poststenotic narrowing of the
ICA is associated with a low risk of stroke with medical
treatment and that carotid endarterectomy (CEA) was
less beneﬁcial than for severe stenosis without NO or post-
stenotic narrowing of the ICA.3-5
Distal embolism and decreased cerebral perfusion are
important mechanisms of stroke in patients with carotid
artery stenosis. However, the signiﬁcant reduction of bloodthe Departments of Neurosurgerya and Public Health,b Yamaguchi
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2ﬂow across the stenosis in patients with NO reduces the
risk of brain embolization and may be a major reason the
incidence of ischemic stroke for medically treated patients
with NO is lower than that in patients with severe stenosis
without NO.2,4 On the other hand, cerebral hemody-
namics might be more compromised in patients with
NO, and carotid revascularization may improve cerebral
hemodynamics and, consequently, prevent ischemic stroke.
The cerebral hemodynamic consequences of NO have not
been examined, however.
Carotid artery stenting (CAS) has recently become
recognized as a therapeutic alternative for patients with
ICA stenosis, and the safety and efﬁcacy of CAS for patients
with NO have also been described.2,6-8 In this study, we
used single-photon emission computed tomography
(SPECT) to investigate the hemodynamic effects of CAS
in patients with NO.
METHODS
The Yamaguchi University Ethics Committee ap-
proved the CAS procedure and the study. All patients
gave informed consent to treatment and participation in
the study.
Patients. The participants were 15 consecutive
patients (14 men) with NO who underwent CAS at our
hospital between July 2006 and June 2012. Patients were
a mean age of 70.6 years (range, 60-77 years). Ten patients
were symptomatic, with minor stokes or transient ischemic
attacks, and ﬁve were asymptomatic. Two patients had
contralateral ICA stenosis of $70%.
JOURNAL OF VASCULAR SURGERY
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cerebral hemodynamics in 78 patients (68 men) with
severe stenosis ($70%) but without NO of the ICA, and
their data were used for comparison with patients with
NO of the ICA. The patients without NO were a mean
age of 71.0 years (range, 47-83 years), 40 were symptom-
atic with minor stokes or transient ischemic attacks, 17 had
contralateral ICA stenosis of $70%, and seven had contra-
lateral ICA occlusion.
Before CAS, all patients underwent four-vessel angiog-
raphy for conﬁrmation of NO of the ICA. The criteria for
identiﬁcation of NO were (1) delayed cranial arrival of ICA
contrast compared with the external carotid artery (ECA);
(2) intracranial collaterals seen as cross-ﬁlling of contralat-
eral vessels or ipsilateral contrast dilution; (3) obvious
diameter reduction (>50%) of the ICA compared with
the opposite ICA; or (4) ICA diameter reduction
compared with the ipsilateral ECA, as deﬁned by Fox
et al, with some modiﬁcation. As noted by Fox et al,9
NO was considered to be present when two or more of
these criteria were recognized. The 15 patients classiﬁed
with NO in this study met three or more of the criteria.
Of the 78 patients classiﬁed without NO, 45 met one crite-
rion and all had visible collaterals (criterion 2). During
angiography, collateral ﬂow was evaluated from the ante-
rior communicating artery, posterior communicating
artery, ECA, and leptomeningeal arteries. In the patients
without NO, the degree of stenosis was determined using
the NASCET criteria, and the mean degree of stenosis
was 85.0% 6 6.5% (range, 70%-95%).10
Within 2 weeks before the procedure, all patients were
assessed with duplex and color ﬂow Doppler ultrasound
imaging, brain computed tomography (CT), and magnetic
resonance (MR) imaging, including MR angiography and
SPECT. All patients received two of three antiplatelet
drugs before treatment (100 mg aspirin, 75 mg clopidog-
rel, 200 mg cilostazol).
CAS was performed by two operators at our hospital,
with the patient under local anesthesia. A distal protection
device was used in all cases. Brain CT was performed in all
patients immediately after CAS. To conﬁrm vessel patency
and detect possible restenosis, duplex ultrasound imaging
was performed 1 week after the procedure, at 3, 6, and
12 months for the ﬁrst year, and then annually. SPECT
was performed 3 to 6 months after the procedure.
Using the same methods, we performed SPECT in 13
healthy individuals (ﬁve men and eight women) to obtain
control values for resting cerebral blood ﬂow (CBF) and
cerebrovascular reactivity (CVR). These individuals were
a mean age of 61.2 years (range, 47-78 years), and none
had stenosis or occlusion of cervical or intracranial arteries.
Informed consent was obtained from each participant.
CBF measurement and image analysis. CBF was
evaluated using SPECT, which was performed twice
#2 weeks before and 3 to 6 months after CAS for patients
with NO and for those with severe stenosis but without
NO of the ICA. Resting CBF and CVR were measured
in one session using the dual-table autoradiographic(DTARG) method and dual administration of
N-isopropyl-p-[I-123] iodoamphetamine(123I-IMP), as
described in detail elsewhere.11,12 For SPECT with drug
challenge, acetazolamide (17 mg/kg, 1000-mg maximum)
was administered intravenously. Whole-blood radioactivity
was measured with a well counter calibrated to the SPECT
apparatus. For the ﬁrst and second scans, all frames were
summed and images were reconstructed as described
below. SPECT was performed with a three-headed
gamma-camera (GCA-9300A/PI; Toshiba Medical
Systems, Tokyo, Japan) and a low-energy, high-resolution
fan beam collimator. GMS-550A/PI (Toshiba Medical
Systems) was used to convert fan beam data to parallel
data.
The tomography images were reconstructed and CBF
quantiﬁcation was performed using the QSPECT image
reconstruction package developed by Kim et al11 and Iida
et al.13 After image reconstruction, image processing was
achieved with the program based on stereotactic extraction
estimation from the Japanese EC-IC bypass trial, with
three-dimensional stereotactic surface projection.14 This
program automatically measures CBF values at rest and
after acetazolamide challenge for the territories of the ante-
rior cerebral artery, middle cerebral artery (MCA), and
posterior cerebral artery, and can also calculate the CVR,
as follows: [CVR ¼ 100  (acetazolamide CBF e resting
CBF)/resting CBF]. In patients who received CAS, data
from the MCA territory on the ipsilateral side to CAS
were used in the analysis. Normal control values of resting
CBF (32.23 6 2.36 mL/100 g/min) and CVR (42.3% 6
16.0%) in the territory of the MCA in our hospital were ob-
tained in 13 healthy individuals. There was no signiﬁcant
difference in age and sex between the controls and the
patient groups. The reproducibility and accuracy of quanti-
tative CBF measurements using the QSPECT/DTARG
method have been reported.11,13,15
Statistical analysis. Descriptive data are presented as
means 6 standard deviation. A paired t-test was used to
compare paired data from preoperative and postoperative
SPECT. An analysis of variance, followed by the post hoc
Bonferroni test, was used to compare SPECT data between
patients with NO, those with severe stenosis without NO,
and the healthy controls. The Fisher test was used to
compare clinical characteristics and postoperative outcome
between patients with NO and those with severe stenosis
without NO. Differences were deemed signiﬁcant if the
probability value was <.05. All calculations were performed
using StatView 5.0 software (SAS Institute, Cary, NC).
RESULTS
CAS was successfully performed in all patients. One
patients with NO developed transient motor aphasia due
to ischemic stroke 1 day after the procedure, which was
conﬁrmed by diffusion-weighed MRI; however, this disap-
peared in a few days, and he was discharged with no neuro-
logic deﬁcit. In another patient, CT immediately after CAS
detected an asymptomatic slight subarachnoid hemor-
rhage. The cause was thought to be hyperperfusion, and





P(n ¼ 15) (n ¼ 78)
Age, years 70.6 (60-77) 71.9 (47-83) .47
Male-to-female ratio 14:1 68:10 .69
Degree of stenosis, % e 85.0 6 6.5
Symptomatic lesion 10 (66.7) 40 (51.3) .40
Contralateral stenosis ($70%) 2 (13.3) 17 (30.8) .73
Contralateral occlusion 0 (0) 7 (8.9) .59
Outcome
#30 days after CAS
Ischemic stroke 1 (6.6) 1 (1.2) .30
Intracranial hemorrhage 1b (6.6) 0 (0) .16
>30 days after CAS
Ipsilateral ischemic stroke 0 (0) 0 (0) >.99
Restenosis (>50%) 0 (0) 4 (5.1) >.99
CAS, Carotid artery stenting; NO, near occlusion.
aContinuous data are shown as mean (range) or mean 6 standard deviation
and categoric data as number (%).
bSubarachnoid hemorrhage.
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No other complication occurred in the 30-day period after
the procedure. Clinical follow-up was performed for all
patients, and no cerebral ischemic attacks occurred on
the side ipsilateral to CAS during a mean follow-up of
40 months. No patient showed restenosis >50%. Among
the patients without NO, one developed minor ischemic
stroke, but no intracranial hemorrhage was observed. No
other complication occurred in the 30-day period after
the procedure. Clinical follow-up was performed for all
patients, and the mean follow-up period was 38 months.
No patient experienced ischemic stroke ipsilateral to
CAS. Asymptomatic restenosis of >50% occurred in four
patients and was >70% in one of these patients. This
patient was successfully treated with percutaneous translu-
minal angioplasty. The basic characteristics and postopera-
tive outcome for the 15 patients with NO and 78 patients
with severe stenosis without NO are reported in Table I.
Before CAS, the mean resting CBF on the ipsilateral
side of the MCA area was 26.68 6 4.23 mL/100 g/min,
and the mean CVR was 0.8% 6 15.1% in the 15 patients
with NO. In 12 these patients (80%) the CVR was <10%,
and eight (53%) had decreased CBF after the Diamox chal-
lenge; a so-called steal phenomenon (Table II). In patients
without NO, mean resting CBF and mean CVR were
29.516 4.89 mL/100 g/min and 19.3%6 20.0%, respec-
tively, and results were signiﬁcantly lower in patients with
NO than in those with severe stenosis without NO of the
ICA (Fig 1).
After CAS, the mean resting CBF and mean CVR were
both signiﬁcantly increased to 30.076 5.67 mL/100 g/min
and 37.0% 6 21.4%, respectively, in the patients with NO
(Table II). In patients without NO, CVR increased signif-
icantly after CAS, and the mean resting CBF showed
a tendency for an increase, but this was not signiﬁcant
(Fig 2). There were no signiﬁcant differences between
the two groups (Fig 1). Before CAS, mean resting CBFand CVR were signiﬁcantly lower in both groups than in
healthy controls, and those differences disappeared after
the procedure (Fig 1).DISCUSSION
In this study, we investigated cerebral hemodynamics
quantitatively using SPECT before and after CAS in
patients with NO of the ICA. We also measured CBF in
patients with severe stenosis but without NO of the ICA
and in healthy controls. The results showed that cerebral
hemodynamics were further compromised before CAS in
patients with NO. However, resting CBF and CVR both
increased chronically after CAS, and signiﬁcant differences
among the three groups disappeared.
In patients with NO, reduction of blood ﬂow across
the stenosis may reduce the risk of brain embolization.
Using transcranial Doppler scanning, Molloy and Mar-
kus16 found a signiﬁcant reduction of microemboli
when the degree of stenosis >90%, and this might be
particularly in patients with poststenotic narrowing.4
This may be a major reason the incidence of ischemic
stroke for medically treated patients with NO is lower
than that in patients with severe stenosis without
NO.3,5,9 In contrast, cerebral perfusion might decrease
more in patients with NO. Previous studies have exam-
ined cerebral hemodynamics of patients with NO, but
a quantitative analysis has not been performed. Using
transcranial Doppler ultrasound imaging, Gonzalez
et al2 found that one-third of 116 patients with NO of
the ICA had exhausted or diminished vasoreactivity in
response to apnea. In brain perfusion analysis by MR or
SPECT in 27 of 48 patients with NO, Choi et al6 found
perfusion deﬁcits were severe in 17 and moderate in 10,
and no patients had normal perfusion. In SPECT in 12
of 20 patients with NO, Terada et al7 found that six
showed reduction of CBF and poor reactivity to a Diamox
challenge test. However, these three studies did not
include a quantitative analysis or a comparison with
patients without NO, making it difﬁcult to understand if
NO patients are hemodynamically compromised. In this
study, we quantiﬁed CBF using SPECT and compared
the results for patients with NO and those with severe
stenosis without NO. Resting CBF and CVR were both
signiﬁcantly lower in the patients with NO, consistent
with our hypothesis of compromised hemodynamics in
these patients.
After CAS, resting CBF and CVR were signiﬁcantly
improved in patients with NO, and these values became
similar to those for patients with severe stenosis without
NO and for those in the healthy controls. Improvement of
CBF and CVR after CEA has been shown in many
reports,17-21 and thus, CEA is also expected to improve cere-
bral hemodynamics in patients with NO. The effect of
improved cerebral hemodynamics after revascularization
on prevention of ischemic stroke is uncertain, but decreased
resting CBF and CVR measured by SPECT have been re-
ported as risk factors for future ischemic stroke.22,23
Table II. Hemodynamic changes in the ipsilateral middle cerebral artery (MCA) area before and at 3 to 6 months after
carotid artery stenting (CAS) in patients with near occlusion (NO)
Patients
Resting CBF, mL/100 g/min CVR, %
Before CAS After CAS (3-6 months) Before CAS After CAS (3-6 months)
1 29.02 42.06 8.9 40.3
2 30.99 27.43 21.2 62.7
3 16.95 21.68 0.3 82.2
4 27.83 25.64 20.5 44.4
5 20.59 32.75 3.3 17.8
6 31.99 34.23 0.1 40.5
7 30.36 36.16 7.2 16.3
8 26.57 27.5 19.5 21.5
9 28.98 28.97 9.5 20.7
10 26.11 27.61 6.8 10.5
11 26 36.3 9 40.1
12 29.85 30.96 27.1 26.7
13 22.04 21.97 14.6 73.9
14 30.5 34.29 28.9 13.4
15 22.47 23.53 5.8 44.1
Mean 6 SD Mean 6 SD Mean 6 SD Mean 6 SD
26.68 6 4.23 30.07 6 5.67a 0.8 6 15.1 37.0 6 21.4b
CBF, Cerebral blood ﬂow; CVR, cerebrovascular reactivity; SD, standard deviation.
aP < .05 vs preoperative investigation.
bP < .01 vs preoperative investigation.
Fig 1. Comparison of mean (left) resting cerebral blood ﬂow (CBF) and (right) mean cerebrovascular reactivity
(CVR) before and after carotid artery stenting (CAS) in patients with near occlusion (NO), in those with stenosis
without NO, and in healthy controls. The error bars indicate the standard deviation. *P < .05; **P < .01.
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ECST, Fox et al9 found a 3-year risk of ipsilateral stroke
of 15.1% for medically treated patients with NO. In our
patients, no cerebral ischemic attacks occurred on the
side ipsilateral to CAS during a mean follow-up of
40 months beginning after the 30-day postprocedural
period. In a study of 116 patients with NO of the ICA,
Gonzalez et al2 found that only one patient (0.8%) experi-
enced a stroke on the side ipsilateral to CAS during
a median follow-up of 36 months, and Terada et al7 alsoshowed that CAS in patients with NO of the ICA has
a long-term effect on prevention of stroke.
Data from the ESCT on long-term outcomes of CEA
for patients with NO showed no beneﬁt in surgically
treated patients with NO, but NASCET and many other
studies have reported a beneﬁt of CEA for preventing
ischemic stroke.3,5,9,24-29 In a study of 53 patients with
NO, Greiner et al26 reported that 95% of patients who
underwent successful CEA had good patency of the treated
artery, without any new neurologic deﬁcits for 4 years.
Fig 2. Changes in mean resting (left) cerebral blood ﬂow (CBF) and (right) cerebrovascular reactivity (CVR) before
and after carotid artery stenting (CAS) in patients with near occlusion (NO) and in those with stenosis without NO.
The error bars indicate standard deviation. *P < .05; **P < .01.
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carotid endarterectomy over medical treatment for patients
with NO. On the basis of these results, the beneﬁt of
carotid revascularization for patients with NO is still uncer-
tain; however, revascularization seems to be effective for
prevention of ischemic stroke in patients with NO of the
ICA, and improvement of cerebral hemodynamics seems
to play an important role. However, a direct comparison
is required to determine the superiority of CEA or CAS
for patients with NO.
In our series, minor ischemic stroke developed in one
patient 1 day after the procedure. Distal embolism is
a major complication of CAS, but a low incidence of
embolic complications during CAS for patients with NO
has been reported. In the largest series of NO patients
treated with CAS, Gonzalez et al2 found that the risk of
ischemic complication was only 3.4% and that all symptoms
were transient. In two other series, there was no distal
embolism during the procedure.6,7 Protection devices are
effective for preventing distal embolism,7 and we used
a distal protection device in all cases, with the result of
no distal embolism during the procedure. However,
patients with NO may have more plaque, and use of
postprocedural intravenous anticoagulants should also be
considered.2 A second patient in our series developed
an asymptomatic subarachnoid hemorrhage associated
with hyperperfusion after the procedure. The risk of hyper-
perfusion after carotid revascularization is high in patients
with severe hemodynamic compromise.30,31 Choi et al6
found an incidence of hyperperfusion of up to 10% and
one death from hyperperfusion-related intracerebral
hemorrhage after CAS in patients with NO of the ICA.6
In contrast, Gonzalez et al2 and Terada et al7 found
no hyperperfusion in 116 and 20 patients with NO, respec-
tively. The reason for this discrepancy is uncertain, but the
possible occurrence of hyperperfusion should be recog-
nized. To prevent this syndrome, strict control of bloodpressure during the postoperative period has been empha-
sized in many reports.32-34
To improve the effectiveness of carotid revascularization
for patients with NO, appropriate patient selection seems
to be required. Some patients in our series had relatively
well-maintained cerebral hemodynamics. In patients with
NO, revascularization may have a low beneﬁt in patients
with maintained CBF, who seem to be at a low risk of stroke
with medical treatment. Although the cutoff value is uncer-
tain and further research is required, assessment of the
cerebral hemodynamic status is likely to be useful to estab-
lish the indication for revascularization in patients with NO.
This study has some limitations that require discussion.
First, the small number of patients requires further studies
to conﬁrm the effectiveness of carotid revascularization for
improving cerebral hemodynamics and preventing ischemic
stroke in patients with NO. Second, we used SPECT,
whereas the most reliable method for hemodynamic assess-
ment is positron-emission tomography (PET). However,
PET facilities are limited by cost and technical complexity,
and decreased resting CBF and CVR to acetazolamide are
related to the increased oxygen extraction fraction assessed
by PET, indicating that this approach could be useful for
screening of patients with misery perfusion.35 The repro-
ducibility and the accuracy of quantitative CBF measure-
ment using the QSPECT/DTARG method that we used
in this study have been reported.11,13,15
CONCLUSIONS
This is the ﬁrst quantitative study of hemodynamic
changes after CAS in patients with NO. Before CAS,
patients with NO were more hemodynamically compro-
mised than those with severe stenosis without NO. After
CAS, signiﬁcant cerebral hemodynamic improvements
and normalization were seen long-term. Further studies
are needed to see if these improvements are effective for
preventing ischemic stroke.
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